MD Anderson Cancer Center Joins Protox Cancer Study
Posted on: Wednesday, 25 October 2006, 15:01 CDT
Protox Therapeutics has reported that the University of Texas MD Anderson Cancer Center has initiated treatment of its first patient in the company's ongoing phase I clinical trial using PRX302 for prostate cancer.
MD Anderson joins the University of Vermont and Scott & White Memorial Hospital in the trial which began treating patients in May 2006.
MD Anderson has joined research into PRX302 following an Institutional Review Board approval.
PRX302 is a pro-drug activated by prostate specific antigen, an enzyme produced in high levels by prostate cancer cells. Once activated, PRX302 reduces the size of a tumor by destroying cancer cells by creating a hole or pore in the cell membrane.
PRX302 is expected to have fewer side effects than traditional or current systemic treatments because it is delivered locally to the prostate.
The phase I trial is intended to examine the safety, tolerability and therapeutic activity of PRX302 in patients with prostate cancer. Protox expects to report interim data from the trial before the end of 2006.
Source: Datamonitor
Related Articles
- Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups
- Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
- Murphy Foundation Launches First-Ever Cancer Prevention Trial in Pet Dogs
- Pancreatic Cancer Therapy Trial Starts
- Cell Therapeutics, Inc. (CTI) Closes PGT305 (PIONEER) Lung Cancer Clinical Trial; New PGT306 Protocol to Be Submitted to FDA By Year End
- Cell Therapeutics, Inc. (CTI) Temporarily Suspends Enrollment on PIONEER Lung Cancer Clinical Trial; Current Patients Continue to Be Treated
- Newsweek Hosts Special Capitol Hill Panel Discussion on 'The New Age of Cancer Clinical Trials: Issues and Opportunities'
- 17,500 Participants Needed to Enroll in Major Colorectal Cancer Clinical Trials; CancerTrialsHelp.Org Launches QuickLink
- Study looks at factors influencing African-American women's decisions to join cancer screening trial
- Powell Has Cancerous Prostate Removed
 |
 |
User Comments (0)
RSS Feeds